Immuneonco Biopharmaceuticals (shanghai) Inc.

This study is testing a new injectable drug, IMC-001, to see if it can safely reduce the volume of a dangerous type of soft plaque in the heart arteries of patients who recently had a heart attack or unstable angina. The trial will enroll 30 participants who are already receiving…

This study is testing whether adding a new drug called IMM01 to standard treatment (azacitidine) works better for adults newly diagnosed with a rare blood cancer called chronic myelomonocytic leukemia (CMML). The main goals are to see if more patients achieve complete remission a…

This is an early-stage study to check the safety and basic effects of a new injection called IMC-003. It will involve 56 healthy women who have gone through menopause. The main goal is to see how the body handles the drug and to identify any side effects.